On 25 August 2020, NCITA launched a national survey on Quality Assurance and Quality Control procedures for MRI equipment in clinical use at research institutions across the UK. The survey is conducted by the NCITA QA/QC Unit, which is developing an MRI core lab to facilitate the validation and standardisation of quality assured imaging biomarkers from first-in-human studies to multicentre reproducibility assessment.
The survey is designed to ascertain the current status of clinical MRI scanner equipment availability, QA/QC practices and quality management procedures at research institutions across the UK to establish how the NCITA MRI core lab can best support clinical studies using MR imaging biomarker readouts.
Representatives from all UK research institutions and centres that conduct clinical MRI imaging biomarker studies are invited to complete the survey in accordance with the instructions and privacy notices provided in the following link (click here).
The deadline for completing the survey is 4 October 2020.
If you are interested in finding out more information on the survey, please contact the NCITA QA/QC team at email@example.com